scispace - formally typeset
Journal ArticleDOI

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis

Reads0
Chats0
TLDR
A consensus of opinions on the diagnosis, treatment, prognosis and prevention of CanL is presented, and a system of four clinical stages, based on clinical signs, clinicopathological abnormalities and serological status is proposed.
About
This article is published in Veterinary Parasitology.The article was published on 2009-10-28. It has received 526 citations till now. The article focuses on the topics: Subclinical infection & Serology.

read more

Citations
More filters
Journal ArticleDOI

Canine leishmaniosis in the Old and New Worlds: unveiled similarities and differences

TL;DR: The similarities and differences between canine leishmaniosis in the Old and New Worlds are outlined, with emphasis on South America and Europe, and calls the attention of veterinary and public health authorities to standardize and improve practices for diagnosing, treating, and preventing the disease.
Journal ArticleDOI

LeishVet update and recommendations on feline leishmaniosis

TL;DR: This report presents in this report a review of the current knowledge on FeL, the epidemiological role of the cat in L. infantum infection, clinical manifestations, and recommendations on diagnosis, treatment and monitoring, prognosis and prevention of infection, in order to standardize the management of this disease in cats.
Journal ArticleDOI

Laboratory tests for diagnosing and monitoring canine leishmaniasis

TL;DR: Dogs with overt leishmaniasis generally have high antibody titers, while low titers predominate in immunologically resistant infected dogs or in exposed dogs with no parasite confirmation.
References
More filters
Journal ArticleDOI

Leishmaniasis: current situation and new perspectives.

TL;DR: Research for leishmaniasis has been more and more focusing on the development of new tools such as diagnostic tests, drugs and vaccines, and the newly available control tools should allow a scaling up of control activities in priority areas.
Journal ArticleDOI

Advances in leishmaniasis.

TL;DR: Governed by parasite and host factors and immunoinflammatory responses, the clinical spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral).
Journal ArticleDOI

Drug Resistance in Leishmaniasis

TL;DR: It is essential that there be a strategy to prevent the emergence of resistance to new drugs; combination therapy, monitoring of therapy, and improved diagnostics could play an essential role in this strategy.
Journal ArticleDOI

The Relationship between Leishmaniasis and AIDS: the Second 10 Years

TL;DR: Based on the previous experience of 20 years of coinfection in Europe, this review focuses on the management of Leishmania-HIV-coinfected patients in low-income countries where leishmaniasis is endemic.
Journal ArticleDOI

Leishmaniasis and poverty.

TL;DR: Public investment in treatment and control would decrease the leishmaniasis disease burden and help to alleviate poverty.
Related Papers (5)